1. Contractors
  2. Biocartis US Inc

Biocartis US Inc

Federal contractor · In-Vitro Diagnostic Substance Manufacturing

Biocartis US has 1 federal contract of $100,000 or more active since October 2023, with $114K obligated, from 1 agency. 1 is still running, 1 ending within 18 months.

Contracts
1 since FY2024$113,842 obligated, contracts of $100,000 or more
Running now
1 contract
Biggest customer
Department of Veterans Affairs$114K on 1 contract
UEI
RY27EUE8U9B7Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Cpt - Cancer Reagents/IdyllaDepartment of Veterans Affairs · 36C24722P0776$113,842May 15, 2027in 5 monthsNJ

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
Department of Veterans Affairs1 contract$113,842

What they sell

IndustryAmount
In-Vitro Diagnostic Substance ManufacturingNAICS 325413 · 1 contract$113,842

Where the work is

Place of workAmount
New Jersey1 contract$113,842

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Department of Veterans Affairs: see the list.

Get new notices like Biocartis US's work

New contract opportunities under NAICS 325413, in-vitro diagnostic substance manufacturing, the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy